Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the activity of those successful funds in these small-cap stocks. In the following paragraphs, we analyze GTx, Inc. (NASDAQ:GTXI) from the perspective of those successful funds.
GTx, Inc. (NASDAQ:GTXI) investors should pay attention to an increase in hedge fund interest of late. There were 3 hedge funds in our database with GTXI holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Psychemedics Corp. (NASDAQ:PMD), Manning and Napier Inc (NYSE:MN), and Cell Therapeutics Inc (NASDAQ:CTIC) to gather more data points.
Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)
Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)
At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.
RAJ CREATIONZS / shutterstock.com
Keeping this in mind, we’re going to check out the fresh action regarding GTx, Inc. (NASDAQ:GTXI).
What have hedge funds been doing with GTx, Inc. (NASDAQ:GTXI)?
Heading into the fourth quarter of 2016, a total of 6 of the hedge funds tracked by Insider Monkey were long this stock, a boost of 100% from the second quarter of 2016. The graph below displays the number of hedge funds with bullish position in GTXI over the last 5 quarters. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Biotechnology Value Fund / BVF Inc, led by Mark Lampert, holds the biggest position in GTx, Inc. (NASDAQ:GTXI). According to regulatory filings, the fund has a $9 million position in the stock, comprising 1.7% of its 13F portfolio. Coming in second is D E Shaw, one of the largest hedge funds in the world, with a $0.1 million position; the fund has less than 0.1% of its 13F portfolio invested in the stock. Other peers with similar optimism encompass Jim Simons’s Renaissance Technologies, Ken Griffin’s Citadel Investment Group and Paul Tudor Jones’s Tudor Investment Corp. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.
